Immuron Limited American Depositary Shares
Symbol: IMRN (NASDAQ)
1.91
▼ (-0.78%) -0.015
Company Description:
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
Key Stats
- Today's Open: $1.9127
- Today's High: $1.915
- Today's Low: $1.86
- Today's Volume: 17.63K
- Yesterday Close: $1.92
- Yesterday High: $1.93
- Yesterday Low: $1.8344
- Yesterday Volume: 66.90K
- Last Min Volume: 1
- Last Min High: $1.905
- Last Min Low: $1.905
- Last Min VWAP: $1.905
Company Profile
- Name: Immuron Limited American Depositary Shares
- Website: https://www.immuron.com.au
- Listed Date: 2007-12-13
- Location: ,
- Market Status: Active
- CIK Number: 0001660046
- SIC Code:
- SIC description:
- Market Cap: $12.87M
- Round Lot: 100
- Outstanding Shares: 6.71M
- Asset Type: ADRC
RECENT FILINGS FOR IMRN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-02 | 6-K | View |
| 2025-08-26 | 6-K | View |
| 2025-08-15 | 6-K | View |
| 2025-08-13 | 6-K | View |
| 2025-07-21 | 6-K | View |
| 2025-07-18 | 6-K | View |
| 2025-07-17 | 6-K | View |
| 2025-07-17 | 6-K | View |
| 2025-06-04 | 6-K | View |
| 2025-05-30 | 6-K | View |
| 2025-04-11 | 6-K | View |
| 2025-04-10 | 6-K | View |
| 2025-03-07 | 6-K | View |
| 2025-03-05 | 6-K | View |
| 2025-02-28 | 6-K | View |
| 2025-02-19 | 6-K | View |
| 2025-01-17 | 6-K | View |
| 2025-01-15 | 6-K | View |
| 2025-01-14 | 6-K | View |
| 2025-01-10 | 6-K | View |
Latest News on IMRN